2. Others JAK/STAT Signaling Protein Tyrosine Kinase/RTK
  3. Isotope-Labeled Compounds EGFR
  4. Dosimertinib-d3

Dosimertinib-d3 是一种有效的口服活性 EGFR 抑制剂。Dosimertinib-d3 降低 p-EGFR 和 p-ERK 蛋白水平的表达。Dosimertinib-d3 显示出抗增殖和抗肿瘤活性。Dosimertinib-d3 具有非小细胞肺癌 (NSCLC) 研究的潜力。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Dosimertinib-d<sub>3</sub> Chemical Structure

Dosimertinib-d3 Chemical Structure

CAS No. : 2403760-70-1

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
1 mg 询价
5 mg 询价

* Please select Quantity before adding items.

Customer Review

Other Forms of Dosimertinib-d3:

Dosimertinib-d3 相关抗体

Top Publications Citing Use of Products

查看 EGFR 亚型特异性产品:

查看所有亚型
EGFR/ErbB1/HER1 ErbB2/HER2 ErbB3/HER3 ErbB4/HER4

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Dosimertinib-d3-d3 is a potent and orally active EGFR inhibitor. Dosimertinib-d3-d3 decreases the expression of p-EGFR and p-ERK protein levels. Dosimertinib-d3-d3 shows antiproliferative and anti-tumor activity. Dosimertinib-d3-d3 has the potential for the research of non-small-cell lung cancer (NSCLC)[1].

体外研究
(In Vitro)

Dosimertinib (compound 2h) (1, 10, 100, 100 nM; 2h) 以剂量依赖性方式降低 p-EGFR 和 p-ERK 蛋白水平[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Dosimertinib-d3 相关抗体:

Cell Proliferation Assay[1]

Cell Line: A431, H1975, EGFR-L858/T790M BaF3, EGFR-del19/T790M BaF3 Cells
Concentration: 0-10 µM
Incubation Time: 72 h
Result: Showed antiproliferative activity with IC50s of 243.9, 28.4, 18.0, 3.5 nM for A431, H1975, EGFR-L858/T790M BaF3, EGFR-del19/T790M BaF3 cells, respectively.

Western Blot Analysis[1]

Cell Line: A431, H1975 cells
Concentration: 1, 10, 100, 100 nM
Incubation Time: 2 h
Result: Decreased the expression of p-EGFR and p-ERK protein levels in a dose-dependent mannet when co-incubationed with 50 ng/mL EGF.
体内研究
(In Vivo)

Dosimertinib (0.75、1.5、3 mg/kg；口服，每天一次，持续 24 天) 在小鼠体内显示出抗肿瘤活性[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 18-20 g, BALB/c nude mice (H1975 mouse xenograft model)[1]
Dosage: 0.75, 1.5, 3 mg/kg
Administration: Oral gavage; daily for 24 days
Result: Significantly reduced tumor size with tumor growth inhibition (TGI) of 72.94% and 97.62% at 1.5, 3 mg/kg, respectively.
分子量

504.64

Formula

C28H28D5N7O2
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

Dosimertinib-d3 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Dosimertinib-d32403760-70-1Isotope-Labeled CompoundsEGFREpidermal growth factor receptorErbB-1HER1p-EGFRp-ERKNSCLCorally activeantiproliferativeanti-tumorInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Dosimertinib-d3
目录号：
HY-142283
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z